Your browser doesn't support javascript.
loading
Benzodiazepine Use in Older Adults in the United States, Ontario, and Australia from 2010 to 2016.
Brett, Jonathan; Maust, Donovan T; Bouck, Zach; Ignacio, Rosalinda V; Mecredy, Graham; Kerr, Eve A; Bhatia, Sacha; Elshaug, Adam G; Pearson, Sallie A.
Afiliação
  • Brett J; Medicines Policy Research Unit, Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Maust DT; Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
  • Bouck Z; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan.
  • Ignacio RV; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan.
  • Mecredy G; Institute for Health Systems Solutions and Virtual Care, Women's College Hospital, Toronto, Ontario, Canada.
  • Kerr EA; Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
  • Bhatia S; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan.
  • Elshaug AG; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan.
  • Pearson SA; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
J Am Geriatr Soc ; 66(6): 1180-1185, 2018 07.
Article em En | MEDLINE | ID: mdl-29430639
ABSTRACT

OBJECTIVES:

To detail annual trends in benzodiazepine incidence and prevalence in older adults between 2010 and 2016 in three countries.

DESIGN:

Observational multicountry cohort study with harmonized study protocol.

SETTING:

The United States (veteran population); Ontario, Canada; and Australia.

PARTICIPANTS:

All people aged 65 and older (8,270,000 people). MEASUREMENTS Annual incidence and prevalence of benzodiazepine use stratified according to age group (65-74, 75-84, ≥85) and sex. We performed multiple regression analyses to assess whether rates of incident and prevalent use changed significantly over time.

RESULTS:

Over the study period, we observed a significant decrease in incident benzodiazepine use in the United States (2.6% to 1.7%) and Ontario (6.0% to 4.4%) but not Australia (7.0% to 6.7%). We found significant declines in prevalent use in all countries (United States 9.2% to 7.3%; Ontario 18.2% to 13.4%; Australia 20.2% to 16.8%). Although incidence and prevalence increased with age in Ontario and Australia, they decreased with age in the United States. Incidence and prevalence were higher in women in all countries.

CONCLUSION:

Consistent with other international studies, there have been small but significant reductions in the incidence and prevalence of benzodiazepine use in older adults in all three countries, with the exception of incidence in Australia, although use remains inappropriately high-particularly in those aged 85 and older-which warrants further attention from clinicians and policy-makers.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Benzodiazepinas / Padrões de Prática Médica / Revisão de Uso de Medicamentos / Uso Excessivo de Medicamentos Prescritos Tipo de estudo: Clinical_trials / Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male País como assunto: America do norte / Oceania Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Benzodiazepinas / Padrões de Prática Médica / Revisão de Uso de Medicamentos / Uso Excessivo de Medicamentos Prescritos Tipo de estudo: Clinical_trials / Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male País como assunto: America do norte / Oceania Idioma: En Ano de publicação: 2018 Tipo de documento: Article